THOR is a targetable epigenetic biomarker with clinical implications in breast cancer.

Clin Epigenetics · 2022 · PMC9759897 · PMID 36529814

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

ductal: 39.96%); however, these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.